NASDAQ:AUXL - Auxilium Pharmaceuticals Stock Price, Price Target & More

$36.47 0.00 (0.00 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$36.47
Today's RangeN/A
52-Week Range$17.10 - $37.92
VolumeN/A
Average Volume1.32 million shs
Market Capitalization$1.85 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.66

About Auxilium Pharmaceuticals (NASDAQ:AUXL)

Auxilium Pharmaceuticals logoAuxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company that focuses on developing and marketing products to predominantly specialist audiences. Its core therapeutic focus continues to be in the area of urology, with an anchor position in men's healthcare. The company's products include Testim (testosterone gel) and testosterone gel are indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; TESTOPEL offers men an option that provides a long-acting androgenic effect; Striant (testosterone buccal system) CIII is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; STENDRA is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction; among others.

Receive AUXL News and Ratings via Email

Sign-up to receive the latest news and ratings for AUXL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
SymbolNASDAQ:AUXL
CUSIP05334D10
Phone+1-484-3215900

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-29.78%
Return on Equity-76.75%
Return on Assets-11.59%

Miscellaneous

EmployeesN/A
Outstanding Shares51,020,000

How to Become a New Pot Stock Millionaire

Auxilium Pharmaceuticals (NASDAQ:AUXL) Frequently Asked Questions

What is Auxilium Pharmaceuticals' stock symbol?

Auxilium Pharmaceuticals trades on the NASDAQ under the ticker symbol "AUXL."

How were Auxilium Pharmaceuticals' earnings last quarter?

Auxilium Pharmaceuticals Inc (NASDAQ:AUXL) released its quarterly earnings data on Thursday, October, 30th. The biopharmaceutical company reported $0.27 EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.03) by $0.30. The biopharmaceutical company had revenue of $109.60 million for the quarter, compared to the consensus estimate of $101.02 million. Auxilium Pharmaceuticals had a negative net margin of 29.78% and a negative return on equity of 76.75%. The company's quarterly revenue was up 1.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.17 earnings per share. View Auxilium Pharmaceuticals' Earnings History.

Who are some of Auxilium Pharmaceuticals' key competitors?

Has Auxilium Pharmaceuticals been receiving favorable news coverage?

Media coverage about AUXL stock has been trending somewhat positive this week, according to Accern. The research firm rates the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Auxilium Pharmaceuticals earned a daily sentiment score of 0.16 on Accern's scale. They also assigned news stories about the biopharmaceutical company an impact score of 47.44 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

How do I buy shares of Auxilium Pharmaceuticals?

Shares of AUXL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Auxilium Pharmaceuticals' stock price today?

One share of AUXL stock can currently be purchased for approximately $36.47.

How big of a company is Auxilium Pharmaceuticals?

Auxilium Pharmaceuticals has a market capitalization of $1.85 billion.

How can I contact Auxilium Pharmaceuticals?

Auxilium Pharmaceuticals' mailing address is 640 Lee Rd, CHESTERBROOK, PA 19087-5636, United States. The biopharmaceutical company can be reached via phone at +1-484-3215900.


MarketBeat Community Rating for Auxilium Pharmaceuticals (AUXL)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  225 (Vote Outperform)
Underperform Votes:  170 (Vote Underperform)
Total Votes:  395
MarketBeat's community ratings are surveys of what our community members think about Auxilium Pharmaceuticals and other stocks. Vote "Outperform" if you believe AUXL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AUXL will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Auxilium Pharmaceuticals (NASDAQ:AUXL) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/21/2016 forward)

Earnings

Auxilium Pharmaceuticals (NASDAQ:AUXL) Earnings History and Estimates Chart

Earnings by Quarter for Auxilium Pharmaceuticals (NASDAQ:AUXL)

Auxilium Pharmaceuticals (NASDAQ AUXL) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/30/2014Q314($0.03)$0.27$101.02 million$109.60 millionViewN/AView Earnings Details
8/7/2014Q214($0.21)($0.54)$482.80 million$83.00 millionViewListenView Earnings Details
5/5/2014Q114($0.14)($0.39)$89.20 million$8.50 millionViewListenView Earnings Details
2/28/2014Q413$0.22$0.27$111.83 million$125.90 millionViewListenView Earnings Details
11/6/2013Q3 2013$0.05$0.10$102.49 million$108.10 millionViewN/AView Earnings Details
8/1/2013Q2 2013($0.03)$0.02$91.43 million$100.50 millionViewListenView Earnings Details
4/29/2013Q1 2013$0.02($0.05)$81.23 million$66.20 millionViewListenView Earnings Details
2/26/2013Q4 2012$1.72$1.83$171.20 million$172.50 millionViewListenView Earnings Details
11/7/2012Q312($0.07)($0.21)$79.54 million$71.00 millionViewN/AView Earnings Details
7/31/2012($0.05)$0.16ViewN/AView Earnings Details
5/10/2012($0.11)($0.04)ViewN/AView Earnings Details
2/23/2012($0.16)($0.25)ViewN/AView Earnings Details
10/31/2011($0.20)($0.08)ViewN/AView Earnings Details
8/1/2011($0.19)($0.11)ViewN/AView Earnings Details
5/9/2011($0.24)($0.25)ViewN/AView Earnings Details
2/10/2011($0.30)($0.34)ViewN/AView Earnings Details
11/4/2010Q3 2010($0.30)($0.27)ViewN/AView Earnings Details
8/5/2010Q2 2010($0.25)($0.28)ViewN/AView Earnings Details
5/3/2010Q1 2010($0.31)($0.18)ViewN/AView Earnings Details
2/17/2010Q4 2009($0.31)($0.25)ViewN/AView Earnings Details
10/28/2009Q3 2009($0.31)($0.35)ViewN/AView Earnings Details
8/6/2009Q2 2009($0.29)($0.32)ViewN/AView Earnings Details
5/6/2009Q1 2009($0.26)($0.31)ViewN/AView Earnings Details
2/18/2009Q4 2008($0.25)($0.29)ViewN/AView Earnings Details
10/29/2008Q3 2008($0.28)($0.24)ViewN/AView Earnings Details
7/31/2008Q2 2008($0.30)($0.29)ViewN/AView Earnings Details
4/30/2008Q1 2008($0.32)($0.30)ViewN/AView Earnings Details
2/14/2008Q4 2007($0.28)($0.29)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Auxilium Pharmaceuticals (NASDAQ:AUXL) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Auxilium Pharmaceuticals (NASDAQ AUXL) Insider Trading and Institutional Ownership History

Insider Trading History for Auxilium Pharmaceuticals (NASDAQ:AUXL)

Auxilium Pharmaceuticals (NASDAQ AUXL) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/5/2014Adrian AdamsCEOSell40,000$33.97$1,358,800.00View SEC Filing  
12/5/2014Paul A FriedmanDirectorSell29,689$33.73$1,001,409.97View SEC Filing  
12/3/2014Oliver FetzerDirectorSell100,000$34.02$3,402,000.00View SEC Filing  
11/25/2014James Patrick TursiInsiderSell13,713$34.12$467,887.56View SEC Filing  
11/21/2014Andrew I KovenCAOSell139,683$33.43$4,669,602.69View SEC Filing  
11/21/2014James Patrick TursiInsiderSell74,648$33.19$2,477,567.12View SEC Filing  
11/21/2014Jennifer Lou ArmstrongSVPSell75,803$33.50$2,539,400.50View SEC Filing  
3/14/2014Tito Benjamin Del, Jr.EVPSell32,032$29.50$944,944.0022,735View SEC Filing  
3/5/2014Rolf ClassonDirectorSell10,000$31.85$318,500.0022,937View SEC Filing  
12/13/2013Tito Benjamin Del, Jr.EVPSell4,602$20.50$94,341.0013,710View SEC Filing  
12/11/2013James FickenscherCFOSell71,067$20.37$1,447,634.7945,132View SEC Filing  
8/15/2013Oliver FetzerDirectorSell1,900$18.75$35,625.0014,197View SEC Filing  
5/20/2013William MckeeDirectorSell2,000$15.10$30,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Auxilium Pharmaceuticals (NASDAQ AUXL) News Headlines

Source:
DateHeadline
Reviewing Baxalta (BXLT) & Auxilium Pharmaceuticals (AUXL)Reviewing Baxalta (BXLT) & Auxilium Pharmaceuticals (AUXL)
www.americanbankingnews.com - March 22 at 12:25 PM
Head-To-Head Review: Auxilium Pharmaceuticals (AUXL) versus VIVUS (VVUS)Head-To-Head Review: Auxilium Pharmaceuticals (AUXL) versus VIVUS (VVUS)
www.americanbankingnews.com - February 14 at 3:18 AM
Contrasting Auxilium Pharmaceuticals (AUXL) & Mediwound (MDWD)Contrasting Auxilium Pharmaceuticals (AUXL) & Mediwound (MDWD)
www.americanbankingnews.com - February 6 at 1:28 PM
Head-To-Head Contrast: Alexion Pharmaceuticals (ALXN) vs. Auxilium Pharmaceuticals (AUXL)Head-To-Head Contrast: Alexion Pharmaceuticals (ALXN) vs. Auxilium Pharmaceuticals (AUXL)
www.americanbankingnews.com - January 11 at 9:32 AM
Cesca Therapeutics (KOOL) and Auxilium Pharmaceuticals (AUXL) Head to Head ContrastCesca Therapeutics (KOOL) and Auxilium Pharmaceuticals (AUXL) Head to Head Contrast
www.americanbankingnews.com - January 4 at 11:08 PM
Reviewing Auxilium Pharmaceuticals (AUXL) & The CompetitionReviewing Auxilium Pharmaceuticals (AUXL) & The Competition
www.americanbankingnews.com - December 17 at 9:28 PM
Contrasting Auxilium Pharmaceuticals (AUXL) and Its CompetitorsContrasting Auxilium Pharmaceuticals (AUXL) and Its Competitors
www.americanbankingnews.com - December 17 at 8:28 AM
Analyzing Auxilium Pharmaceuticals (AUXL) and Its CompetitorsAnalyzing Auxilium Pharmaceuticals (AUXL) and Its Competitors
www.americanbankingnews.com - December 11 at 3:34 PM
Auxilium Pharmaceuticals (AUXL) versus Its Peers Head-To-Head SurveyAuxilium Pharmaceuticals (AUXL) versus Its Peers Head-To-Head Survey
www.americanbankingnews.com - December 10 at 7:20 PM
Comparing Auxilium Pharmaceuticals (AUXL) and Its PeersComparing Auxilium Pharmaceuticals (AUXL) and Its Peers
www.americanbankingnews.com - December 8 at 8:40 AM
Comparing Auxilium Pharmaceuticals (AUXL) and Its CompetitorsComparing Auxilium Pharmaceuticals (AUXL) and Its Competitors
www.americanbankingnews.com - December 4 at 5:12 AM
Reviewing Auxilium Pharmaceuticals (AUXL) & Its CompetitorsReviewing Auxilium Pharmaceuticals (AUXL) & Its Competitors
www.americanbankingnews.com - December 3 at 9:48 PM
Analyzing Auxilium Pharmaceuticals (AUXL) & Its PeersAnalyzing Auxilium Pharmaceuticals (AUXL) & Its Peers
www.americanbankingnews.com - November 26 at 9:18 PM
Critical Analysis: Auxilium Pharmaceuticals (AUXL) versus The CompetitionCritical Analysis: Auxilium Pharmaceuticals (AUXL) versus The Competition
www.americanbankingnews.com - November 25 at 1:22 AM
Auxilium Pharmaceuticals (AUXL) versus Its Peers Critical ContrastAuxilium Pharmaceuticals (AUXL) versus Its Peers Critical Contrast
www.americanbankingnews.com - November 19 at 11:30 AM
Critical Analysis: Auxilium Pharmaceuticals (AUXL) vs. Peregrine Pharmaceuticals (PPHM)Critical Analysis: Auxilium Pharmaceuticals (AUXL) vs. Peregrine Pharmaceuticals (PPHM)
www.americanbankingnews.com - November 10 at 7:32 PM
Auxilium Pharmaceuticals (AUXL) versus KalVista Pharmaceuticals (KALV) Head to Head SurveyAuxilium Pharmaceuticals (AUXL) versus KalVista Pharmaceuticals (KALV) Head to Head Survey
www.americanbankingnews.com - October 23 at 4:32 AM
Fortress Biotech (FBIO) & Auxilium Pharmaceuticals (AUXL) Critical ComparisonFortress Biotech (FBIO) & Auxilium Pharmaceuticals (AUXL) Critical Comparison
www.americanbankingnews.com - October 20 at 8:32 AM
Auxilium Pharmaceuticals (AUXL) & Onconova Therapeutics (ONTX) Critical ComparisonAuxilium Pharmaceuticals (AUXL) & Onconova Therapeutics (ONTX) Critical Comparison
www.americanbankingnews.com - October 15 at 4:08 PM
Head-To-Head Review: Auxilium Pharmaceuticals (AUXL) versus BioMarin Pharmaceutical (BMRN)Head-To-Head Review: Auxilium Pharmaceuticals (AUXL) versus BioMarin Pharmaceutical (BMRN)
www.americanbankingnews.com - September 28 at 10:48 AM
Financial Survey: Auxilium Pharmaceuticals (AUXL) versus Alimera Sciences (ALIM)Financial Survey: Auxilium Pharmaceuticals (AUXL) versus Alimera Sciences (ALIM)
www.americanbankingnews.com - September 7 at 8:28 PM
Auxilium Pharmaceuticals (NASDAQ:AUXL) vs. Biogen (BIIB) Head to Head AnalysisAuxilium Pharmaceuticals (NASDAQ:AUXL) vs. Biogen (BIIB) Head to Head Analysis
www.americanbankingnews.com - July 24 at 8:22 PM
Endo International (ENDP) Earnings Report: Q1 2015 Conference Call TranscriptEndo International (ENDP) Earnings Report: Q1 2015 Conference Call Transcript
www.thestreet.com - May 11 at 2:46 PM
AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial Statements aAUXILIUM PHARMACEUTICALS INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial Statements a
biz.yahoo.com - January 30 at 4:56 PM
AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a MateriaAUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Materia
biz.yahoo.com - January 29 at 4:50 PM
AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation FD DAUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation FD D
biz.yahoo.com - January 27 at 1:38 PM
AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Other EventsAUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events
biz.yahoo.com - January 21 at 6:01 AM
AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsAUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - December 22 at 11:16 AM
AUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal OfficersAUXILIUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - December 19 at 1:12 PM
Why Endo Wants to Acquire Auxilium So MuchWhy Endo Wants to Acquire Auxilium So Much
247wallst.com - September 17 at 10:05 AM

SEC Filings

Auxilium Pharmaceuticals (NASDAQ:AUXL) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Auxilium Pharmaceuticals (NASDAQ:AUXL) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Auxilium Pharmaceuticals (NASDAQ AUXL) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.